References
1. VRAYLAR (cariprazine) [package insert]. Madison, NJ: Allergan USA, Inc.; 2019.
2. Data on file. Allergan.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-5. 5th ed. American Psychiatric Association; 2013.
4. Awad AG, Rajagopalan K, Bolge SC, McDonnell DD. Prim Care Companion J Clin Psychiatry. 2007;9(3):195-202.
5. Manning JS. Prim Care Companion J Clin Psychiatry. 2005;7(6):259-267.
6. Perlis RH. Am J Manag Care. 2005;11(9 suppl):S271-S274.
7. Hirschfeld RM. J Affect Disord. 2014;169(suppl 1);S12-S16.
8. Hirschfeld RMA, Cass AR, Holt DCL, Carlson CA. J Am Board Fam Pract. 2005;18(4):233-239.
9. Hu J, Mansur R, McIntyre RS. Prim Care Companion CNS Disord. 2014;16(2).
10. Montgomery SA, Asberg M. Br J Psychiatry. 1979;134(4):382-389.
11. Young RC, Biggs JT, Ziegler VE, Meyer DA. Br J Psychiatry. 1978;133:429-435.
12. McIntyre RS, Soczynska JK, Cha DS, et al. J Affect Disord. 2015;172:259-264.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. DSM-IV-TR. American Psychiatric Association; 2000.
14. Durgam S, Earley W, Lipschitz A, et al. Am J Psychiatry. 2016;173(3):271-281.
15. Earley W, Burgess MV, Rekeda L, et al. Am J Psychiatry. 2019;176(6):439-448.
16. Earley WR, Burgess MV, Khan B, et al. Bipolar Disord. 2020;22(4):372-384.
17. Data on file. Post-Hoc Analysis. Allergan.
18. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Clin Pract Epidemiol Ment Health. 2007;3(5):1-8.
19. Calabrese JR, Keck PE Jr, Starace A, et al. J Clin Psychiatry. 2015;76(3):284-292.
20. Durgam S, Starace A, Li D, et al. Bipolar Disord. 2015;17(1):63-75.
21. Sachs GS, Greenberg WM, Starace A, et al. J Affect Disord. 2015;174:296-302.
22. Vieta E, Durgam S, Lu K, Ruth A, Debelle M, Zukin S. Eur Neuropsychopharmacol. 2015;25(11):1882-1891.
23. Lieberman JA. CNS Drugs. 2004;18(4):251-267.
24. Stahl SM, Laredo S, Morrissette D. Ther Adv Psychopharmacol. 2020;10:1-11.
25. Durgam S, Starace A, Li D, et al. Schizophr Res. 2014;152(2-3):450-457.
26. Durgam S, Cutler AJ, Lu K, et al. J Clin Psychiatry. 2015;76(12):e1574-e1582.
27. Kane JM, Zukin S, Wang Y, et al. J Clin Psychopharmacol. 2015;35(4):367-373.
28. Durgam S, Earley W, Li R, et al. Schizophr Res. 2016;176(2-3):264-271.
29. Kay SR, Fiszbein A, Opler LA. Schizophr Bull. 1987;13(2):261-276.
- VRAYLAR (cariprazine) [package insert]. Madison, NJ: Allergan USA, Inc.; 2022.
- Data on file. AbbVie.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-5. 5th ed. American Psychiatric Association; 2013.
- Awad AG, Rajagopalan K, Bolge SC, McDonnell DD. Prim Care Companion J Clin Psychiatry. 2007;9(3):195-202.
- Manning JS. Prim Care Companion J Clin Psychiatry. 2005;7(6):259-267.
- Perlis RH. Am J Manag Care. 2005;11(9 suppl):S271-S274.
- Hirschfeld RM. J Affect Disord. 2014;169(suppl 1);S12-S16.
- Hirschfeld RMA, Cass AR, Holt DCL, Carlson CA. J Am Board Fam Pract. 2005;18(4):233-239.
- Hu J, Mansur R, McIntyre RS. Prim Care Companion CNS Disord. 2014;16(2).
- Montgomery SA, Asberg M. Br J Psychiatry. 1979;134(4):382-389.
- Young RC, Biggs JT, Ziegler VE, Meyer DA. Br J Psychiatry. 1978;133:429-435.
- McIntyre RS, Soczynska JK, Cha DS, et al. J Affect Disord. 2015;172:259-264.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. DSM-IV-TR. American Psychiatric Association; 2000.
- Durgam S, Earley W, Lipschitz A, et al. Am J Psychiatry. 2016;173(3):271-281.
- Earley W, Burgess MV, Rekeda L, et al. Am J Psychiatry. 2019;176(6):439-448.
- Earley WR, Burgess MV, Khan B, et al. Bipolar Disord. 2020;22(4):372-384.
- Data on file. Post-Hoc Analysis. Allergan.
- Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Clin Pract Epidemiol Ment Health. 2007;3(5):1-8.
- Calabrese JR, Keck PE Jr, Starace A, et al. J Clin Psychiatry. 2015;76(3):284-292.
- Durgam S, Starace A, Li D, et al. Bipolar Disord. 2015;17(1):63-75.
- Sachs GS, Greenberg WM, Starace A, et al. J Affect Disord. 2015;174:296-302.
- Vieta E, Durgam S, Lu K, Ruth A, Debelle M, Zukin S. Eur Neuropsychopharmacol. 2015;25(11):1882-1891.
- Lieberman JA. CNS Drugs. 2004;18(4):251-267.
- Stahl SM, Laredo S, Morrissette D. Ther Adv Psychopharmacol. 2020;10:1-11.
- Durgam S, Starace A, Li D, et al. Schizophr Res. 2014;152(2-3):450-457.
- Durgam S, Cutler AJ, Lu K, et al. J Clin Psychiatry. 2015;76(12):e1574-e1582.
- Kane JM, Zukin S, Wang Y, et al. J Clin Psychopharmacol. 2015;35(4):367-373.
- Durgam S, Earley W, Li R, et al. Schizophr Res. 2016;176(2-3):264-271.
- Kay SR, Fiszbein A, Opler LA. Schizophr Bull. 1987;13(2):261-276.
- McIntyre RS, Patel MD, Prakash SM, et al. Curr Med Res Opin. 2021;37(1):135-144. doi:10.1080/03007995.2020.1860358